about
Aberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets?Antisense oligonucleotides: rising stars in eliminating RNA toxicity in myotonic dystrophy.Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies.Targeting RNA to treat neuromuscular disease.Faulty splicing and cytoskeleton abnormalities in Huntington's disease.HTS-Compatible Patient-Derived Cell-Based Assay to Identify Small Molecule Modulators of Aberrant Splicing in Myotonic Dystrophy Type 1.Design of a "Mini" Nucleic Acid Probe for Cooperative Binding of an RNA-Repeated Transcript Associated with Myotonic Dystrophy Type 1.
P2860
Q35019375-64E97800-A9AD-411E-ADC3-66BA23ED9D25Q36848720-293202C7-C630-4160-B437-34C27BAD85FBQ37619968-410A24B2-2849-439C-B1C0-BB392D7A71A9Q37909000-E09549DC-5786-4913-808A-2755A7B7CAA4Q38928751-5B6EC75F-884A-4293-8486-05330462A28FQ39700299-DB23A900-399F-4670-8082-C8E50EFA14DEQ48242863-F62E990B-01C0-423B-80E5-C0E5221CC230
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Molecular biology. Neutralizing toxic RNA.
@en
type
label
Molecular biology. Neutralizing toxic RNA.
@en
prefLabel
Molecular biology. Neutralizing toxic RNA.
@en
P2860
P356
P1433
P1476
Molecular biology. Neutralizing toxic RNA.
@en
P2093
Thomas A Cooper
P2860
P304
P356
10.1126/SCIENCE.1177452
P407
P577
2009-07-01T00:00:00Z